Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis
Abstract
:1. Introduction
2. Obesity and Breast Cancer Survival
3. Hyperinsulinaemia, Hyperglycemia and Type 2 Diabetes Mellitus with Breast Cancer Outcome
4. Dyslipidaemia and Prognosis of Breast Cancer
5. Hypertension and Prognosis of Breast Cancer
6. Summary
References
- Agnoli, C.; Berrino, F.; Abagnato, C.A.; Muti, P.; Panico, S.; Crosignani, P.; Krogh, V. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 41–48. [Google Scholar] [CrossRef]
- Pasanisi, P.; Berrino, F.; De Petris, M.; Venturelli, E.; Mastroianni, A.; Panico, S. Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int. J. Cancer. 2006, 119, 236–238. [Google Scholar] [CrossRef]
- Alberti, K.G.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998, 15, 539–553. [Google Scholar] [CrossRef]
- Denke, M. A.; Pasternak, R.C. Defining and Treating the Metabolic Syndrome: A Primer from the Adult Treatment Panel III. Curr. Treat. Options. Cardiovasc. Med. 2001, 3, 251–253. [Google Scholar] [CrossRef]
- Alberti, K. G.; Zimmet, P.; Shaw, J. The metabolic syndrome--a new worldwide definition. Lancet 2005, 366, 1059–1062. [Google Scholar] [CrossRef]
- Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.J. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120, 1640–1645. [Google Scholar] [CrossRef]
- Furberg, A.S.; Veierod, M.B.; Wilsgaard, T.; Bernstein, L.; Thune, I. Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk. J. Natl. Cancer Inst. 2004, 96, 1152–1160. [Google Scholar] [CrossRef]
- Morimoto, L.M.; White, E.; Chen, Z.; Chlebowski, R.T.; Hays, J.; Kuller, L.; Lopez, A.M.; Manson, J.; Margolis, K.L.; Muti, P.C.; et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States). Cancer Causes Contr. 2002, 13, 741–751. [Google Scholar] [CrossRef]
- Folsom, A.R.; Kaye, S.A.; Prineas, R.J.; Potter, J.D.; Gapstur, S.M.; Wallace, R.B. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am. J. Epidemiol. 1990, 131, 794–803. [Google Scholar]
- Peeters, P.H.; van Noord, P.A.; Hoes, A.W.; Fracheboud, J.; Gimbrere, C.H.; Grobbee, D.E. Hypertension and breast cancer risk in a 19-year follow-up study (the DOM cohort). Diagnostic investigation into mammarian cancer. J. Hypertens. 2000, 18, 249–254. [Google Scholar] [CrossRef]
- Muti, P.; Quattrin, T.; Grant, B. J.; Krogh, V.; Micheli, A.; Schunemann, H.J.; Ram, M.; Freudenheim, J.L.; Sieri, S.; Trevisan, M.; Berrino, F. Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1361–1368. [Google Scholar]
- Lipscombe, L.L.; Goodwin, P.J.; Zinman, B.; McLaughlin, J.R.; Hux, J.E. Diabetes mellitus and breast cancer: a retrospective population-based cohort study. Breast Cancer Res. Treat. 2006, 98, 349–356. [Google Scholar] [CrossRef]
- Donegan, W.L.; Hartz, A.J.; Rimm, A.A. The association of body weight with recurrent cancer of the breast. Cancer 1978, 41, 1590–1594. [Google Scholar] [CrossRef]
- Borugian, M.J.; Sheps, S.B.; Kim-Sing, C.; Olivotto, I.A.; Van Patten, C.; Dunn, B.P.; Coldman, A.J.; Potter, J.D.; Gallagher, R.P.; Hislop, T.G. Waist-to-hip ratio and breast cancer mortality. Am. J. Epidemiol. 2003, 158, 963–968. [Google Scholar] [CrossRef]
- Tao, M.H.; Shu, X.O.; Ruan, Z.X.; Gao, Y.T.; Zheng, W. Association of overweight with breast cancer survival. Am. J. Epidemiol. 2006, 163, 101–107. [Google Scholar]
- Lipscombe, L.L.; Goodwin, P.J.; Zinman, B.; McLaughlin, J.R.; Hux, J.E. The impact of diabetes on survival following breast cancer. Breast Cancer Res. Treat. 2008, 109, 389–395. [Google Scholar] [CrossRef]
- Irwin, M.L.; McTiernan, A.; Bernstein, L.; Gilliland, F.D.; Baumgartner, R.; Baumgartner, K.; Ballard-Barbash, R. Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 2881–2888. [Google Scholar] [CrossRef]
- Peeters, P.H.; van Noord, P.A.; Hoes, A.W.; Grobbee, D.E. Hypertension, antihypertensive drugs, and mortality from cancer among women. J. Hypertens. 1998, 16, 941–947. [Google Scholar] [CrossRef]
- Josefson, D. High insulin levels linked to deaths from breast cancer. BMJ 2000, 320, 1496. [Google Scholar] [CrossRef]
- Procopiou, M.; Philippe, J. The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc. Dis. 2005, 20 (Suppl. 1), 2–8. [Google Scholar] [CrossRef]
- Tartter, P.I.; Papatestas, A.E.; Ioannovich, J.; Mulvihill, M.N.; Lesnick, G.; Aufses, A.H., Jr. Cholesterol and obesity as prognostic factors in breast cancer. Cancer 1981, 47, 2222–2227. [Google Scholar] [CrossRef]
- Chlebowski, R.T.; Aiello, E.; McTiernan, A. Weight loss in breast cancer patient management. J. Clin. Oncol. 2002, 20, 1128–1143. [Google Scholar] [CrossRef]
- Boyd, N.F.; Campbell, J.E.; Germanson, T.; Thomson, D.B.; Sutherland, D.J.; Meakin, J.W. Body weight and prognosis in breast cancer. J. Natl. Cancer Inst. 1981, 67, 785–789. [Google Scholar]
- Goodwin, P.J.; Esplen, M.J.; Winocur, J.; Butler, K.; Pritchard, K.I. Development of a Weight Management Program in Women with Newly Diagnosed Locoregional Breast Cancer; Bitzer, J., Stauber, M., Eds.; Psychosomatic Obstetrics and Gynecology: Bologna, Italy, 1995; pp. 491–496. [Google Scholar]
- Greenberg, E.R.; Vessey, M.P.; McPherson, K.; Doll, R.; Yeates, D. Body size and survival in premenopausal breast cancer. Br. J. Cancer 1985, 51, 691–697. [Google Scholar] [CrossRef]
- Kroenke, C.H.; Chen, W.Y.; Rosner, B.; Holmes, M.D. Weight, weight gain, and survival after breast cancer diagnosis. J. Clin. Oncol. 2005, 23, 1370–1378. [Google Scholar] [CrossRef]
- Obermair, A.; Kurz, C.; Hanzal, E.; Bancher-Todesca, D.; Thoma, M.; Bodisch, A.; Kubista, E.; Kyral, E.; Kaider, A.; Sevelda, P.; et al. The influence of obesity on the disease-free survival in primary breast cancer. Anticancer Res. 1995, 15, 2265–2269. [Google Scholar]
- Healy, L.A.; Ryan, A.M.; Rowley, S.; Boyle, T.; Connolly, E.; Kennedy, M.J.; Reynolds, J.V. Obesity increases the risk of postmenopausal breast cancer and is associated with more advanced stage at presentation but no impact on survival. Breast J. 2010, 16, 95–97. [Google Scholar] [CrossRef]
- Carmichael, A.R. Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 2006, 113, 1160–1166. [Google Scholar] [CrossRef]
- Carmichael, A.R. Obesity and prognosis of breast cancer. Obes. Rev. 2006, 7, 333–340. [Google Scholar] [CrossRef]
- Carmichael, A.R.; Bates, T. Obesity and breast cancer: a review of the literature. Breast 2004, 13, 85–92. [Google Scholar] [CrossRef]
- Barnett, J.B. The relationship between obesity and breast cancer risk and mortality. Nutr. Rev. 2003, 61, 73–76. [Google Scholar] [CrossRef]
- Goodwin, P.J.; Boyd, N.F. Body size and breast cancer prognosis: a critical review of the evidence. Breast Cancer Res. Treat. 1990, 16, 205–214. [Google Scholar] [CrossRef]
- Daling, J.R.; Malone, K.E.; Doody, D.R.; Johnson, L.G.; Gralow, J.R.; Porter, P.L. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma. Cancer 2001, 92, 720–729. [Google Scholar] [CrossRef]
- Loi, S.; Milne, R. L.; Friedlander, M. L.; McCredie, M. R.; Giles, G. G.; Hopper, J. L.; Phillips, K. A. Obesity and outcomes in premenopausal and postmenopausal breast cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 1686–1691. [Google Scholar] [CrossRef]
- Abrahamson, P.E.; Gammon, M.D.; Lund, M.J.; Flagg, E. W.; Porter, P. L.; Stevens, J.; Swanson, C.A.; Brinton, L.A.; Eley, J.W.; Coates, R.J. General and abdominal obesity and survival among young women with breast cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15, 1871–1877. [Google Scholar] [CrossRef]
- Rosenberg, L.; Czene, K.; Hall, P. Obesity and poor breast cancer prognosis: an illusion because of hormone replacement therapy? Br. J. Cancer 2009, 100, 1486–1491. [Google Scholar] [CrossRef]
- Reeves, K.W.; Faulkner, K.; Modugno, F.; Hillier, T.A.; Bauer, D.C.; Ensrud, K.E.; Cauley, J.A. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures. Cancer Epidemiol. Biomarkers Prev. 2007, 16, 1468–1473. [Google Scholar] [CrossRef]
- Newman, S.C.; Lees, A.W.; Jenkins, H.J. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients. Int. J. Epidemiol. 1997, 26, 484–490. [Google Scholar] [CrossRef]
- Tretli, S.; Haldorsen, T.; Ottestad, L. The effect of pre-morbid height and weight on the survival of breast cancer patients. Br. J. Cancer 1990, 62, 299–303. [Google Scholar] [CrossRef]
- Caan, B. J.; Kwan, M. L.; Hartzell, G.; Castillo, A.; Slattery, M.L.; Sternfeld, B.; Weltzien, E. Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer. Cancer Causes Contr. 2008, 19, 1319–1328. [Google Scholar] [CrossRef]
- Chen, X.; Lu, W.; Zheng, W.; Gu, K.; Chen, Z.; Zheng, Y.; Shu, X.O. Obesity and weight change in relation to breast cancer survival. Breast Cancer Res. Treat. 2010. [Google Scholar] [CrossRef]
- Dignam, J.J.; Wieand, K.; Johnson, K.A.; Raich, P.; Anderson, S.J.; Somkin, C.; Wickerham, D.L. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res. Treat. 2006, 97, 245–254. [Google Scholar] [CrossRef]
- Kyogoku, S.; Hirohata, T.; Takeshita, S.; Nomura, Y.; Shigematsu, T.; Horie, A. Survival of breast-cancer patients and body size indicators. Int. J. Cancer 1990, 46, 824–831. [Google Scholar] [CrossRef]
- Rose, D.P.; Haffner, S.M.; Baillargeon, J. Adiposity, the metabolic syndrome, and breast cancer in African-American and white American women. Endocr. Rev. 2007, 28, 763–777. [Google Scholar] [CrossRef]
- Gu, K.; Chen, X.; Zheng, Y.; Chen, Z.; Zheng, W.; Lu, W.; Shu, X.O. Weight change patterns among breast cancer survivors: results from the Shanghai breast cancer survival study. Cancer Causes Contr. 2009. [Google Scholar] [CrossRef]
- Demark-Wahnefried, W.; Rimer, B.K.; Winer, E.P. Weight gain in women diagnosed with breast cancer. J. Am. Diet Assoc. 1997, 97, 519–526, 529, 527–528. [Google Scholar] [CrossRef]
- Nichols, H.B.; Trentham-Dietz, A.; Egan, K.M.; Titus-Ernstoff, L.; Holmes, M.D.; Bersch, A.J.; Holick, C.N.; Hampton, J.M.; Stampfer, M.J.; Willett, W.C.; et al. Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality. Cancer Epidemiol. Biomarkers Prev. 2009, 18, 1403–1409. [Google Scholar] [CrossRef]
- Loprinzi, C.L.; Athmann, L.M.; Kardinal, C.G.; O'Fallon, J.R.; See, J.A.; Bruce, B.K.; Dose, A.M.; Miser, A.W.; Kern, P.S.; Tschetter, L.K.; Rayson, S. Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology 1996, 53, 228–232. [Google Scholar] [CrossRef]
- Demark-Wahnefried, W.; Peterson, B.L.; Winer, E.P.; Marks, L.; Aziz, N.; Marcom, P. K.; Blackwell, K.; Rimer, B.K. Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy. J. Clin. Oncol. 2001, 19, 2381–2389. [Google Scholar]
- Dal Maso, L.; Zucchetto, A.; Talamini, R.; Serraino, D.; Stocco, C.F.; Vercelli, M.; Falcini, F.; Franceschi, S. Effect of obesity and other lifestyle factors on mortality in women with breast cancer. Int. J. Cancer 2008, 123, 2188–2194. [Google Scholar] [CrossRef]
- Zhang, S.; Folsom, A.R.; Sellers, T.A.; Kushi, L.H.; Potter, J.D. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer 1995, 76, 275–283. [Google Scholar] [CrossRef]
- Deglise, C.; Bouchardy, C.; Burri, M.; Usel, M.; Neyroud-Caspar, I.; Vlastos, G.; Chappuis, P.O.; Ceschi, M.; Ess, S.; Castiglione, M.; et al. Impact of obesity on diagnosis and treatment of breast cancer. Breast Cancer Res. Treat. 2010, 120, 185–193. [Google Scholar] [CrossRef]
- Kirschner, M.A.; Samojlik, E.; Drejka, M.; Szmal, E.; Schneider, G.; Ertel, N. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J. Clin. Endocrinol. Metab. 1990, 70, 473–479. [Google Scholar] [CrossRef]
- Kaye, S.A.; Folsom, A.R.; Soler, J.T.; Prineas, R.J.; Potter, J.D. Associations of body mass and fat distribution with sex hormone concentrations in postmenopausal women. Int. J. Epidemiol. 1991, 20, 151–156. [Google Scholar] [CrossRef]
- Ballard-Barbash, R. Anthropometry and breast cancer. Body size--a moving target. Cancer 1994, 74, 1090–1100. [Google Scholar] [CrossRef]
- Stoll, B.A.; Secreto, G. New hormone-related markers of high risk to breast cancer. Ann. Oncol. 1992, 3, 435–438. [Google Scholar]
- Bruning, P.F. Endogenous estrogens and breast cancer a possible relationship between body fat distribution and estrogen availability. J. Steroid. Biochem. 1987, 27, 487–492. [Google Scholar] [CrossRef]
- Stoll, B.A. Obesity and breast cancer. Int. J. Obes. Relat. Metab. Disord. 1996, 20, 389–392. [Google Scholar]
- Hollmann, M.; Runnebaum, B.; Gerhard, I. Impact of waist-hip-ratio and body-mass-index on hormonal and metabolic parameters in young, obese women. Int. J. Obes. Relat. Metab. Disord. 1997, 21, 476–483. [Google Scholar]
- Sant, M.; Francisci, S.; Capocaccia, R.; Verdecchia, A.; Allemani, C.; Berrino, F. Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int. J. Cancer 2006, 119, 2417–2422. [Google Scholar] [CrossRef]
- Kanai, Y. Alterations of DNA methylation and clinicopathological diversity of human cancers. Pathol. Int. 2008, 58, 544–558. [Google Scholar] [CrossRef]
- Hussain, S.P.; Harris, C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 2007, 121, 2373–2380. [Google Scholar] [CrossRef]
- Choi, A.O.; Brown, S.E.; Szyf, M.; Maysinger, D. Quantum dot-induced epigenetic and genotoxic changes in human breast cancer cells. J. Mol. Med. 2008, 86, 291–302. [Google Scholar] [CrossRef]
- Osin, P.; Lu, Y.J.; Stone, J.; Crook, T.; Houlston, R.S.; Gasco, M.; Gusterson, B.A.; Shipley, J. Distinct genetic and epigenetic changes in medullary breast cancer. Int. J. Surg. Pathol. 2003, 11, 153–158. [Google Scholar] [CrossRef]
- Martens, J.W.; Margossian, A.L.; Schmitt, M.; Foekens, J.; Harbeck, N. DNA methylation as a biomarker in breast cancer. Future Oncol. 2009, 5, 1245–1256. [Google Scholar] [CrossRef]
- Dworkin, A.M.; Huang, T H.; Toland, A.E. Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment. Semin. Cancer Biol. 2009, 19, 165–171. [Google Scholar] [CrossRef]
- Reaven, G.M.; Laws, A. Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 1994, 37, 948–952. [Google Scholar] [CrossRef]
- Berrino, F.; Pasanisi, P.; Bellati, C.; Venturelli, E.; Krogh, V.; Mastroianni, A.; Berselli, E.; Muti, P.; Secreto, G. Serum testosterone levels and breast cancer recurrence. Int. J. Cancer 2005, 113, 499–502. [Google Scholar] [CrossRef]
- Goodwin, P.J.; Ennis, M.; Pritchard, K.I.; Trudeau, M.E.; Koo, J.; Madarnas, Y.; Hartwick, W.; Hoffman, B.; Hood, N. Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J. Clin. Oncol. 2002, 20, 42–51. [Google Scholar] [CrossRef]
- Bozcuk, H.; Uslu, G.; Samur, M.; Yildiz, M.; Ozben, T.; Ozdogan, M.; Artac, M.; Altunbas, H.; Akan, I.; Savas, B. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 2004, 27, 58–65. [Google Scholar] [CrossRef]
- Pollak, M.N.; Chapman, J.W.; Shepherd, L.; Meng, D.; Richardson, P.; Wilson, C.; Orme, B.; Pritchard, K.I. Insulin resistance, estimated by serum C-peptide level, is associated with reduced event-free survival for postmenopausal women in NCIC CTG MA. 14 adjuvant breast cancer trial. J. Clin. Oncol. 2006, 24, 524. [Google Scholar]
- Warburg, O. On the origin of cancer cells. Science 1956, 123, 309–314. [Google Scholar]
- Menon, R.K.; Sperling, M.A. Insulin as a growth factor. Endocrinol. Metab. Clin. North Am. 1996, 25, 633–647. [Google Scholar] [CrossRef]
- Belfiore, A.; Frittitta, L.; Costantino, A.; Frasca, F.; Pandini, G.; Sciacca, L.; Goldfine, I.D.; Vigneri, R. Insulin receptors in breast cancer. Ann. N. Y. Acad. Sci. 1996, 784, 173–188. [Google Scholar] [CrossRef]
- Papa, V.; Belfiore, A. Insulin receptors in breast cancer: biological and clinical role. J. Endocrinol. Invest. 1996, 19, 324–333. [Google Scholar]
- Milazzo, G.; Giorgino, F.; Damante, G.; Sung, C.; Stampfer, M.R.; Vigneri, R.; Goldfine, I.D.; Belfiore, A. Insulin receptor expression and function in human breast cancer cell lines. Cancer Res. 1992, 52, 3924–3930. [Google Scholar]
- Cullen, K.J.; Yee, D.; Sly, W.S.; Perdue, J.; Hampton, B.; Lippman, M.E.; Rosen, N. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res. 1990, 50, 48–53. [Google Scholar]
- Mulligan, A.M.; O'Malley, F. P.; Ennis, M.; Fantus, I.G.; Goodwin, P.J. Insulin receptor is an independent predictor of a favorable outcome in early stage breast cancer. Breast Cancer Res. Treat. 2007, 106, 39–47. [Google Scholar] [CrossRef]
- Papa, V.; Pezzino, V.; Costantino, A.; Belfiore, A.; Giuffrida, D.; Frittitta, L.; Vannelli, G.B.; Brand, R.; Goldfine, I.D.; Vigneri, R. Elevated insulin receptor content in human breast cancer. J. Clin. Invest. 1990, 86, 1503–1510. [Google Scholar] [CrossRef]
- Mathieu, M.C.; Clark, G.M.; Allred, D.C.; Goldfine, I.D.; Vigneri, R. Insulin receptor expression and clinical outcome in node-negative breast cancer. Proc. Assoc. Am. Physicians 1997, 109, 565–571. [Google Scholar]
- Haffner, S.M.; Valdez, R.A. Endogenous sex hormones: impact on lipids, lipoproteins, and insulin. Am. J. Med. 1995, 98, 40–47. [Google Scholar] [CrossRef]
- Gustafsson, J.A.; Warner, M. Estrogen receptor beta in the breast: role in estrogen responsiveness and development of breast cancer. J. Steroid. Biochem. Mol. Biol. 2000, 74, 245–248. [Google Scholar] [CrossRef]
- Holden, R.J. The estrogen connection: the etiological relationship between diabetes, cancer, rheumatoid arthritis and psychiatric disorders. Med. Hypotheses 1995, 45, 169–189. [Google Scholar] [CrossRef]
- Kolm, V.; Sauer, U.; Olgemoller, B.; Schleicher, E.D. High glucose-induced TGF-beta 1 regulates mesangial production of heparan sulfate proteoglycan. Am. J. Physiol. 1996, 270, 812–821. [Google Scholar]
- Lewitt, M.S. Role of the insulin-like growth factors in the endocrine control of glucose homeostasis. Diabetes Res. Clin. Pract. 1994, 23, 3–15. [Google Scholar] [CrossRef]
- Reaven, G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988, 37, 1595–1607. [Google Scholar]
- Clemmons, D.R.; Underwood, L.E. Nutritional regulation of IGF-I and IGF binding proteins. Annu. Rev. Nutr. 1991, 11, 393–412. [Google Scholar] [CrossRef]
- Le, R.D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N. Engl. J. Med. 1997, 336, 633–640. [Google Scholar] [CrossRef]
- Lipworth, L.; Adami, H.O.; Trichopoulos, D.; Carlstrom, K.; Mantzoros, C. Serum steroid hormone levels, sex hormone-binding globulin, and body mass index in the etiology of postmenopausal breast cancer. Epidemiology 1996, 7, 96–100. [Google Scholar] [CrossRef]
- Hamelers, I.H.; Steenbergh, P.H. Interactions between estrogen and insulin-like growth factor signaling pathways in human breast tumor cells. Endocr. Relat. Cancer 2003, 10, 331–345. [Google Scholar] [CrossRef]
- Probst-Hensch, N.M.; Steiner, J.H.; Schraml, P.; Varga, Z.; Zurrer-Hardi, U.; Storz, M.; Korol, D.; Fehr, M.K.; Fink, D.; Pestalozzi, B.C.; et al. IGFBP2 and IGFBP3 protein expressions in human breast cancer: association with hormonal factors and obesity. Clin. Cancer Res. 2010, 16, 1025–1032. [Google Scholar] [CrossRef]
- Geier, A.; Beery, R.; Haimsohn, M.; Karasik, A. Insulin-like growth factor-1 inhibits cell death induced by anticancer drugs in the MCF-7 cells: involvement of growth factors in drug resistance. Cancer Invest. 1995, 13, 480–486. [Google Scholar] [CrossRef]
- Pacher, M.; Seewald, M.J.; Mikula, M.; Oehler, S.; Mogg, M.; Vinatzer, U.; Eger, A.; Schweifer, N.; Varecka, R.; Sommergruber, W.; Mikulits, W.; Schreiber, M. Impact of constitutive IGF1/IGF2 stimulation on the transcriptional program of human breast cancer cells. Carcinogenesis 2007, 28, 49–59. [Google Scholar] [CrossRef]
- Yee, D. The insulin-like growth factors and breast cancer--revisited. Breast Cancer Res. Treat. 1998, 47, 197–199. [Google Scholar] [CrossRef]
- Shin, A.; Ren, Z.; Shu, X.O.; Cai, Q.; Gao, Y.T.; Zheng, W. Expression patterns of insulin-like growth factor 1 (IGF-I) and its receptor in mammary tissues and their associations with breast cancer survival. Breast Cancer Res. Treat. 2007, 105, 55–61. [Google Scholar]
- Pasanisi, P.; Venturelli, E.; Morelli, D.; Fontana, L.; Secreto, G.; Berrino, F. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol. Biomarkers Prev. 2008, 17, 1719–1722. [Google Scholar] [CrossRef]
- Bhatavdekar, J.M.; Patel, D.D.; Karelia, N.H.; Vora, H.H.; Ghosh, N.; Shah, N.G.; Balar, D.B.; Trivedi, S.N. Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study. Breast Cancer Res. Treat. 1994, 30, 293–297. [Google Scholar] [CrossRef]
- Barni, S.; Lissoni, P.; Brivio, F.; Fumagalli, L.; Merlini, D.; Cataldo, M.; Rovelli, F.; Tancini, G. Serum levels of insulin-like growth factor-I in operable breast cancer in relation to the main prognostic variables and their perioperative changes in relation to those of prolactin. Tumori 1994, 80, 212–215. [Google Scholar]
- Vadgama, J.V.; Wu, Y.; Datta, G.; Khan, H.; Chillar, R. Plasma insulin-like growth factor-I and serum IGF-binding protein 3 can be associated with the progression of breast cancer, and predict the risk of recurrence and the probability of survival in African-American and Hispanic women. Oncology 1999, 57, 330–340. [Google Scholar] [CrossRef]
- Kim, J.H.; Cho, Y.H.; Park, Y.L.; Sohn, J.H.; Kim, H.S. Prognostic significance of insulin growth factor-I receptor and insulin growth factor binding protein-3 expression in primary breast cancer. Oncol. Rep. 2010, 23, 989–995. [Google Scholar]
- Healy, L.A.; Ryan, A.M.; Carroll, P.; Ennis, D.; Crowley, V.; Boyle, T.; Kennedy, M.J.; Connolly, E.; Reynolds, J.V. Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer. Clin. Oncol. R. Coll. Radiol. 2010. [Google Scholar] [CrossRef]
- Rose, D.P.; Komninou, D.; Stephenson, G.D. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes. Rev. 2004, 5, 153–165. [Google Scholar] [CrossRef]
- Yancik, R.; Havlik, R.J.; Wesley, M.N.; Ries, L.; Long, S.; Rossi, W.K.; Edwards, B.K. Cancer and comorbidity in older patients: a descriptive profile. Ann. Epidemiol. 1996, 6, 399–412. [Google Scholar] [CrossRef]
- Verlato, G.; Zoppini, G.; Bonora, E.; Muggeo, M. Mortality from site-specific malignancies in type 2 diabetic patients from Verona. Diabetes Care 2003, 26, 1047–1051. [Google Scholar] [CrossRef]
- Wolf, I.; Sadetzki, S.; Gluck, I.; Oberman, B.; Ben-David, M.; Papa, M.Z.; Catane, R.; Kaufman, B. Association between diabetes mellitus and adverse characteristics of breast cancer at presentation. Eur. J. Cancer 2006, 42, 1077–1082. [Google Scholar] [CrossRef]
- Larsson, S.C.; Mantzoros, C.S.; Wolk, A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int. J. Cancer 2007, 121, 856–862. [Google Scholar] [CrossRef]
- Coughlin, S.S.; Calle, E.E.; Teras, L.R.; Petrelli, J.; Thun, M. J. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am. J. Epidemiol. 2004, 159, 1160–1167. [Google Scholar] [CrossRef]
- Barone, B.B.; Yeh, H.C.; Snyder, C.F.; Peairs, K.S.; Stein, K.B.; Derr, R.L.; Wolff, A.C.; Brancati, F.L. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 2008, 300, 2754–2764. [Google Scholar] [CrossRef]
- Patterson, R.E.; Flatt, S.W.; Saquib, N.; Rock, C.L.; Caan, B.J.; Parker, B.A.; Laughlin, G.A.; Erickson, K.; Thomson, C.A.; Bardwell, W.A.; Hajek, R.A.; Pierce, J.P. Medical comorbidities predict mortality in women with a history of early stage breast cancer. Breast Cancer Res. Treat. 2010. [Google Scholar] [CrossRef]
- Tseng, C.H.; Chong, C.K.; Tai, T.Y. Secular trend for mortality from breast cancer and the association between diabetes and breast cancer in Taiwan between 1995 and 2006. Diabetologia 2009, 52, 240–246. [Google Scholar] [CrossRef]
- Berglund, G.; Nilsson, P.; Eriksson, K.F.; Nilsson, J.A.; Hedblad, B.; Kristenson, H.; Lindgarde, F. Long-term outcome of the Malmo preventive project: mortality and cardiovascular morbidity. J. Intern. Med. 2000, 247, 19–29. [Google Scholar] [CrossRef]
- Fierz, Y.; Novosyadlyy, R.; Vijayakumar, A.; Yakar, S.; LeRoith, D. Insulin-sensitizing therapy attenuates type 2 diabetes-mediated mammary tumor progression. Diabetes 2010, 59, 686–693. [Google Scholar] [CrossRef]
- Goodwin, P.J.; Pritchard, K.I.; Ennis, M.; Clemons, M.; Graham, M.; Fantus, I.G. Insulin-lowering effects of metformin in women with early breast cancer. Clin. Breast Cancer 2008, 8, 501–505. [Google Scholar] [CrossRef]
- Smith, U.; Gale, E.A. Does diabetes therapy influence the risk of cancer? Diabetologia 2009, 52, 1699–1708. [Google Scholar] [CrossRef]
- Vigneri, P.; Frasca, F.; Sciacca, L.; Pandini, G.; Vigneri, R. Diabetes and cancer. Endocr. Relat. Cancer 2009, 16, 1103–1123. [Google Scholar] [CrossRef]
- Lemachatti, J.; Leveque, D.; Beretz, L.; Bergerat, J. P. Potential pharmacokinetic interactions affecting antitumor drug disposition in cancer patients. Anticancer Res. 2009, 29, 4741–4744. [Google Scholar]
- van de Poll-Franse, L. V.; Houterman, S.; Janssen-Heijnen, M.L.; Dercksen, M.W.; Coebergh, J.W.; Haak, H.R. Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int. J. Cancer 2007, 120, 1986–1992. [Google Scholar] [CrossRef]
- Reaven, G.M. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 2005, 25, 391–406. [Google Scholar] [CrossRef]
- Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z. The metabolic syndrome. Lancet 2005, 365, 1415–1428. [Google Scholar] [CrossRef]
- Fiorenza, A.; Branchi, A.; Sommariva, D. Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int. J. Clin. Lab. Res. 2000, 30, 141–145. [Google Scholar] [CrossRef]
- Franky, D.S.; Shilin, N.S.; Pankaj, M.S.; Patel, H.R.; Prabhudas, S.P. Significance of alterations in plasma lipid profile levels in breast cancer. Integr. Cancer Ther. 2008, 7, 33–41. [Google Scholar] [CrossRef]
- Vatten, L.J.; Foss, O.P.; Kvinnsland, S. Overall survival of breast cancer patients in relation to preclinically determined total serum cholesterol, body mass index, height and cigarette smoking: a population-based study. Eur. J. Cancer 1991, 27, 641–646. [Google Scholar] [CrossRef]
- Tornberg, S.; Carstensen, J. Serum beta-lipoprotein, serum cholesterol and Quetelet's index as predictors for survival of breast cancer patients. Eur. J. Cancer 1993, 29A, 2025–2030. [Google Scholar] [CrossRef]
- Bahl, M.; Ennis, M.; Tannock, I. F.; Hux, J.E.; Pritchard, K.I.; Koo, J.; Goodwin, P.J. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study. Breast Cancer Res. Treat. 2005, 94, 135–144. [Google Scholar] [CrossRef]
- Sakai, K.; Okuyama, H.; Yura, J.; Takeyama, H.; Shinagawa, N.; Tsuruga, N.; Kato, K.; Miura, K.; Kawase, K.; Tsujimura, T.; et al. Composition and turnover of phospholipids and neutral lipids in human breast cancer and reference tissues. Carcinogenesis 1992, 13, 579–584. [Google Scholar] [CrossRef]
- Takatani, O.; Okumoto, T.; Kosano, H. Genesis of breast cancer in Japanese: A possible relationship between sex hormone binding globulin (SHBG) and serum lipid components. Breast Cancer Res. Treat. 1991, 18, 27–29. [Google Scholar] [CrossRef]
- Han, C.; Zhang, H.T.; Du, L.; Liu, X.; Jing, J.; Zhao, X.; Yang, X.; Tian, B. Serum levels of leptin, insulin, and lipids in relation to breast cancer in china. Endocrine 2005, 26, 19–24. [Google Scholar] [CrossRef]
- Gillmer, M.D. Mechanism of action/effects of androgens on lipid metabolism. Int. J. Fertil. 1992, 37 (Suppl. 2), 83–92. [Google Scholar]
- Furberg, A.S.; Jasienska, G.; Bjurstam, N.; Torjesen, P.A.; Emaus, A.; Lipson, S.F.; Ellison, P.T.; Thune, I. Metabolic and hormonal profiles: HDL cholesterol as a plausible biomarker of breast cancer risk. The Norwegian EBBA Study. Cancer Epidemiol. Biomarkers Prev. 2005, 14, 33–40. [Google Scholar]
- Bernstein, L.; Ross, R.K. Endogenous hormones and breast cancer risk. Epidemiol. Rev. 1993, 15, 48–65. [Google Scholar]
- Chahil, T.J.; Ginsberg, H.N. Diabetic dyslipidemia. Endocrinol. Metab. Clin. North Am. 2006, 35, 491–510. [Google Scholar] [CrossRef]
- Ruotolo, G.; Howard, B.V. Dyslipidemia of the metabolic syndrome. Curr. Cardiol. Rep. 2002, 4, 494–500. [Google Scholar] [CrossRef]
- Peeters, P.H.; van Noord, P.A.; Hoes, A.W.; Grobbee, D.E. Hypertension, antihypertensive drugs, and mortality from cancer among women. J. Hypertens. 1998, 16, 941–947. [Google Scholar] [CrossRef]
- Tammemagi, C.M.; Nerenz, D.; Neslund-Dudas, C.; Feldkamp, C.; Nathanson, D. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005, 294, 1765–1772. [Google Scholar] [CrossRef]
- Braithwaite, D.; Tammemagi, C. M.; Moore, D.H.; Ozanne, E.M.; Hiatt, R.A.; Belkora, J.; West, D.W.; Satariano, W.A.; Liebman, M.; Esserman, L. Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients. Int. J. Cancer 2009, 124, 1213–1219. [Google Scholar] [CrossRef]
- Mehta, R.S.; Gunnett, C.A.; Harris, S.R.; Bunce, O.R.; Hartle, D.K. High fish oil diet increases oxidative stress potential in mammary gland of spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 1994, 21, 881–889. [Google Scholar] [CrossRef]
- Ba, D.; Takeichi, N.; Kodama, T.; Kobayashi, H. Restoration of T cell depression and suppression of blood pressure in spontaneously hypertensive rats (SHR) by thymus grafts or thymus extracts. J. Immunol. 1982, 128, 1211–1216. [Google Scholar]
- Norden, A.; Schersten, B.; Thulin, T.; Pero, R.W.; Bryngelsson, C.; Mitelman, F. Letter: Hypertension related to D.N.A. repair synthesis and carcinogen uptake. Lancet 1975, 2, 1094. [Google Scholar]
- Manicardi, V.; Camellini, L.; Bellodi, G.; Coscelli, C.; Ferrannini, E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J. Clin. Endocrinol. Metab. 1986, 62, 1302–1304. [Google Scholar] [CrossRef]
- Reaven, G.M.; Hoffman, B.B. A role for insulin in the aetiology and course of hypertension? Lancet 1987, 2, 435–437. [Google Scholar] [CrossRef]
- Manolio, T.A.; Savage, P.J.; Burke, G.L.; Liu, K.A.; Wagenknecht, L.E.; Sidney, S.; Jacobs, D.R., Jr.; Roseman, J.M.; Donahue, R.P.; Oberman, A. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis 1990, 10, 430–436. [Google Scholar] [CrossRef]
- Saad, M.F.; Knowler, W.C.; Pettitt, D.J.; Nelson, R.G.; Mott, D.M.; Bennett, P.H. Insulin and hypertension. Relationship to obesity and glucose intolerance in Pima Indians. Diabetes 1990, 39, 1430–1435. [Google Scholar]
- Manjer, J.; Kaaks, R.; Riboli, E.; Berglund, G. Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmo Preventive Project. Eur. J. Cancer Prev. 2001, 10, 33–42. [Google Scholar] [CrossRef]
- Esposito, K.; Marfella, R.; Ciotola, M.; Di Palo, C.; Giugliano, F.; Giugliano, G.; D'Armiento, M.; D'Andrea, F.; Giugliano, D. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial. JAMA 2004, 292, 1440–1446. [Google Scholar] [CrossRef] [Green Version]
- Patterson, R.E.; Cadmus, L.A.; Emond, J.A.; Pierce, J.P. Physical activity, diet, adiposity and female breast cancer prognosis: A review of the epidemiologic literature. Maturitas 2010, 66, 5–15. [Google Scholar] [CrossRef]
- Goodwin, P.J. Insulin in the adjuvant breast cancer setting: a novel therapeutic target for lifestyle and pharmacologic interventions? J. Clin. Oncol. 2008, 26, 833–834. [Google Scholar] [CrossRef]
© 2010 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
Share and Cite
Zhu, Q.-L.; Xu, W.-H.; Tao, M.-H. Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis. Cancers 2010, 2, 721-739. https://doi.org/10.3390/cancers2020721
Zhu Q-L, Xu W-H, Tao M-H. Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis. Cancers. 2010; 2(2):721-739. https://doi.org/10.3390/cancers2020721
Chicago/Turabian StyleZhu, Qiu-Li, Wang-Hong Xu, and Meng-Hua Tao. 2010. "Biomarkers of the Metabolic Syndrome and Breast Cancer Prognosis" Cancers 2, no. 2: 721-739. https://doi.org/10.3390/cancers2020721